Menu ×


Cancer Vaccines Market Segmentation By Vaccine (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines); By Indication (Lung Cancer, Prostate Cancer, Cervical Cancer, Liver Cancer and Others); By Technology (Recombinant Vaccine, Dendritic Cells Vaccine, Whole Cell Vaccine, Adjuvant Vaccine and Viral Vector & DNA Vaccine) – Global Demand Analysis & Opportunity Outlook 2028

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • On June 1, 2019, Moderna Inc., a clinical stage biotechnology company involved in developing messenger RNA (mRNA) vaccines and therapies, announced the interim data from its ongoing Phase 1 clinical study that involves patients with both adjuvant and advanced solid tumors. As per the data, the mRNA personalized cancer vaccine mRNA-4157 was reported to be tolerated at all doses.

Introduction to Cancer Vaccines

Cancer can be caused by various factors, viruses being one of them. Viruses such as the human papillomavirus (HPV) and hepatitis B virus (HBV) have been associated with several kinds of cancers in the body. Cancer vaccines are used to kill these infectious agents and thereby treat or prevent cancers that are caused as a result of infections. Cancer vaccines can be either therapeutic or preventive, based on whether it is used for the treatment of an existing cancer or as a preventive measure.

Market Size and Forecast

The cancer vaccines market is anticipated to record a CAGR of around 17.5% over the forecast period, i.e., 2020-2028. The market is segmented by vaccine, by indication, by technology and by region, out of which, the vaccine segment is segmented into therapeutic cancer vaccines and preventive cancer vaccines. The segment for preventive cancer vaccines is anticipated to hold the largest share in the cancer vaccines market on account of growing demand for these vaccines by people for prevention of cancer. Preventive cancer vaccines reduce the risk of infection by cancer causing organisms and help the body to build up immunity against them by creating antibodies. The therapeutic cancer vaccines segment is predicted to grow at the highest rate over the forecast period as a result of high demand for vaccines for the treatment of cancer. Based on technology, the cancer vaccines market is segmented into recombinant vaccine, dendritic cells vaccine, whole cell vaccine, adjuvant vaccine and viral vector & DNA vaccine. According to the National Cancer Institute, the vaccines for prevention of disease causing HPV that are approved for use in the United States include Cervarix, Gardasil and Gardasil 9. These prevent infection from HPV type 16 and 18, which are estimated to cause around 70% of all cervical cancers.

Cancer Vaccines Market Graph

Growth Drivers

Rising Cases of Cancer to Increase the Demand for Cancer Vaccines

The World Health Organization reported that cancer is the second leading cause of death globally, with around 9.6 million deaths in 2018. Around 1 in 6 deaths are as a result of cancer and about 70% of deaths from cancer take place in middle and low income countries. Moreover, it states that infections which cause cancer, such as hepatitis virus and human papilloma virus (HPV), are responsible for around 25% of cancer cases in low and middle income regions. The growing cases of cancer around the world, especially those resulting from cancer causing infections, are predicted to significantly raise the demand for cancer vaccines in the market. CLICK TO DOWNLOAD SAMPLE REPORT 

Side Effects of Alternate Cancer Treatment Methods to Boost the Market Growth

Existing treatments for cancer such as chemotherapy and radiotherapy are linked with certain severe side effects, including hair loss, weight loss and others. In order to avoid these, the demand for alternate treatment methods such as cancer vaccines, which are safer and highly effective, is anticipated to increase over the forecast period.


High Cost of Cancer Vaccines to Hamper the Market Growth

As a result of continuous developments and entrance of improved vaccines in the market regularly, the cost of cancer vaccines is high. The increase in manufacturing expenses is high as well, which is predicted to restrict the entry of small drug manufacturers in the market. On account of high costs, people are less likely to opt for cancer vaccines as a prevention method, which is estimated to hamper the market growth in coming years.

Market Segmentation

Our in-depth analysis of the cancer vaccines market includes the following segments:

By Vaccine

  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines

By Indication

  • Lung Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Liver Cancer
  • Others

By Technology

  • Recombinant Vaccine
  • Dendritic Cells Vaccine
  • Whole Cell Vaccine
  • Adjuvant Vaccine
  • Viral Vector & DNA Vaccine

By Region

On the basis of regional analysis, the cancer vaccines market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

Cancer vaccines market in North America is anticipated to hold the leading share in the market as a result of highly developed healthcare infrastructure as well as presence of leading key players in the market in the region, especially in the United States. The market in Europe is anticipated to hold the second largest share on account of highly advanced technology being used in the region. On the other hand, the market in Asia Pacific is projected to grow at the highest rate over the forecast period as a result of rising cases of cancer in the region and growing presence of leading pharmaceutical and biotechnology companies in the region, especially in China, India and Japan.

Cancer Vaccines Market segmentation image

The cancer vaccines market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC,  Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating the Market


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved